The Enterprise Value as of September 2024 (TTM) for Evolus, Inc. (EOLS) is 1.08B

According to Evolus, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.08B. This represents a change of 54.20% compared to the average of 702.73M of the last 4 quarters.

Evolus, Inc. (EOLS) Historical Enterprise Value (quarterly & annually)

How has EOLS Enterprise Value performed in the past?

The mean historical Enterprise Value of Evolus, Inc. over the last ten years is 340.16M. The current 1.08B Enterprise Value has changed 31.76% with respect to the historical average. Over the past ten years (40 quarters), EOLS's Enterprise Value was at its highest in in the March 2024 quarter at 838.74M. The Enterprise Value was at its lowest in in the March 2016 quarter at 0.

Evolus, Inc. (EOLS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Evolus, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Evolus, Inc. (EOLS) Average Enterprise Value

How has EOLS Enterprise Value performed in the past?

The current Enterprise Value of Evolus, Inc. (EOLS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Evolus, Inc. (EOLS) Enterprise Value vs. Peers

How is EOLS’s Enterprise Value compared to its peers?

Evolus, Inc.’s Enterprise Value is less than Collegium Pharmaceutical, Inc. (1.58B), less than Phibro Animal Health Corporation (1.31B), less than ANI Pharmaceuticals, Inc. (1.26B), greater than Procaps Group S.A. (476.58M), greater than Silver Spike Investment Corp. (38.50M), greater than Eagle Pharmaceuticals, Inc. (110.42M), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Prestige Consumer Healthcare Inc. (4.72B), greater than Pacira BioSciences, Inc. (1.02B), less than Intra-Cellular Therapies, Inc. (7.30B), less than Alkermes plc (4.39B), less than Amphastar Pharmaceuticals, Inc. (2.77B), greater than Ascend Wellness Holdings, Inc. (704.68M), greater than Incannex Healthcare Limited (20.92M), less than Supernus Pharmaceuticals, Inc. (1.71B),

Build a custom stock screener for Evolus, Inc. (EOLS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Evolus, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Evolus, Inc. (EOLS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Evolus, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.